Binding ability of methylene blue with heparin dependent on its sulfate level rather than its sulfation location or basic saccharide structure
- PMID: 34515908
- DOI: 10.1007/s10719-021-10010-2
Binding ability of methylene blue with heparin dependent on its sulfate level rather than its sulfation location or basic saccharide structure
Abstract
Methylene blue (MB) is one of the most common cationic dyes to detect heparin. As the sulfate residue presented in heparin was the main contributor to bind with MB, the UV performance of the MB with selectively desulfated heparin derivatives was investigated. It was found that the sulfate residue in different heparin analogues did not show the equal ability to attract MB binding. The stoichiometry of sulfate with MB among the heparin and derivatives was verified as a non-constant number. For the two selectively desulfated heparin derivatives: sulfate elimination at 6-O (6-OdeS) and N-acetylated heparin (N-deS-Acetyl), the MB to sulfate ratios were significantly higher than for heparin. For the not fully diminished sulfate at 2-O heparin derivative (2-OdeS), the MB-SO3- ratio of 2-OdeS was between 6-OdeS, N-deS-Acetlyl and heparin. Although in a distinct sulfation position, the MB-SO3- ratio of 6-OdeS and N-deS-Acetyl was almost equal, which agreed with the comparable total desulfation degree between 6-OdeS and N-deS-Acetyl. In addition, compared to heparin groups, the non-desulfated gs-HP showed no significantly different MB-SO3- ratio with heparin. The above results demonstrated that compared with the sulfate location and glycan composition of heparin, the content of sulfate was the most essential factor for the MB binding.
Keywords: Heparin; Heparin derivatives; MB-SO3 - ratio; Methylene blue.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
A Mechanistic Investigation of Methylene Blue and Heparin Interactions and Their Photoacoustic Enhancement.Bioconjug Chem. 2018 Nov 21;29(11):3768-3775. doi: 10.1021/acs.bioconjchem.8b00639. Epub 2018 Oct 16. Bioconjug Chem. 2018. PMID: 30281976 Free PMC article.
-
Hydrolytic Degradation of Heparin in Acidic Environments: Nuclear Magnetic Resonance Reveals Details of Selective Desulfation.ACS Appl Mater Interfaces. 2021 Feb 3;13(4):5551-5563. doi: 10.1021/acsami.0c20198. Epub 2021 Jan 20. ACS Appl Mater Interfaces. 2021. PMID: 33471995
-
[Study on the mechanism of the interaction of methylene blue and sulfation pachymaran].Guang Pu Xue Yu Guang Pu Fen Xi. 2005 Apr;25(4):608-12. Guang Pu Xue Yu Guang Pu Fen Xi. 2005. PMID: 16097699 Chinese.
-
Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans.Semin Thromb Hemost. 2002 Aug;28(4):335-42. doi: 10.1055/s-2002-34302. Semin Thromb Hemost. 2002. PMID: 12244480 Review.
-
Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.Molecules. 2019 Dec 17;24(24):4630. doi: 10.3390/molecules24244630. Molecules. 2019. PMID: 31861225 Free PMC article. Review.
Cited by
-
Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.Molecules. 2022 Apr 20;27(9):2654. doi: 10.3390/molecules27092654. Molecules. 2022. PMID: 35566005 Free PMC article.
References
-
- Barrowcliffe, T.W.: History of heparin. Handb. Exp. Pharmacol. 3–22 (2012). https://doi.org/10.1007/978-3-642-23056-1_1
-
- Harenberg, J.: Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function. Int. J. Cardiol. 212, 10–13 (2016). https://doi.org/10.1016/s0167-5273(16)12003-0
-
- Hirsh, J.: Heparin. N. Engl. J. Med. 324, 1565–74 (1991). https://doi.org/10.1056/nejm199105303242206 - DOI - PubMed
-
- Esko, J.D., Selleck, S.B.: Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435–71 (2002). https://doi.org/10.1146/annurev.biochem.71.110601.135458 - DOI - PubMed
-
- Ji, Y., Wang, Y., Zeng, W., et al.: A heparin derivatives library constructed by chemical modification and enzymatic depolymerization for exploitation of non-anticoagulant functions. Carbohydr. Polym. 249, 116824 (2020). https://doi.org/10.1016/j.carbpol.2020.116824 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous